{
     "PMID": "19116183",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20090520",
     "LR": "20161125",
     "IS": "1873-7862 (Electronic) 0924-977X (Linking)",
     "VI": "19",
     "IP": "3",
     "DP": "2009 Mar",
     "TI": "Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain.",
     "PG": "177-87",
     "LID": "10.1016/j.euroneuro.2008.11.001 [doi]",
     "AB": "Asenapine is a psychopharmacologic agent being developed for schizophrenia and bipolar disorder. This study electrophysiologically characterized the in vivo effects of asenapine at dorsal raphe nucleus (DRN) and hippocampus serotonin-1A (5-HT(1A)), ventral tegmental area D(2), locus coeruleus 5-HT(2A,) and alpha(2)-adrenergic receptors in anesthetized rats. Asenapine displayed potent antagonistic activity at alpha(2)-adrenoceptors (ED(50), 85+/-2 microg/kg), 5-HT(2A) (ED(50), 75+/-2 microg/kg) and D(2) receptors (ED(50), 40+/-2 microg/kg) as evidenced by its reversal of clonidine-, DOI-, and apomorphine-induced inhibition of norepinephrine and dopamine neurons. In contrast, asenapine acted as a partial agonist at 5-HT(1A) receptors in DRN and hippocampus, as indicated by blockade of its inhibitory effect on neuronal firing by the 5-HT(1A) antagonist WAY 100635 and the partial inhibition of the suppressant action of 5-HT when co-applied by microiontophoresis. These results confirm that asenapine displays potent antagonistic activity at 5-HT(2A), D(2), alpha(2)-adrenergic receptors and provide evidence to support its 5-HT(1A) partial agonistic activity.",
     "FAU": [
          "Ghanbari, Ramez",
          "El Mansari, Mostafa",
          "Shahid, Mohammed",
          "Blier, Pierre"
     ],
     "AU": [
          "Ghanbari R",
          "El Mansari M",
          "Shahid M",
          "Blier P"
     ],
     "AD": "University of Ottawa Institute of Mental Health Research, 1145 Carling Avenue, Ottawa, Ontario K1Z7K4, Canada. ramez.ghanbari@rohcg.on.ca",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20081229",
     "PL": "Netherlands",
     "TA": "Eur Neuropsychopharmacol",
     "JT": "European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology",
     "JID": "9111390",
     "RN": [
          "0 (Adra2a protein, rat)",
          "0 (Adrenergic alpha-2 Receptor Agonists)",
          "0 (Amphetamines)",
          "0 (Heterocyclic Compounds, 4 or More Rings)",
          "0 (Receptor, Serotonin, 5-HT2A)",
          "0 (Receptors, Adrenergic, alpha-2)",
          "0 (Receptors, Dopamine D2)",
          "0 (Serotonin 5-HT1 Receptor Agonists)",
          "0 (Serotonin 5-HT2 Receptor Agonists)",
          "112692-38-3 (Receptor, Serotonin, 5-HT1A)",
          "78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin)",
          "JKZ19V908O (Asenapine)",
          "MN3L5RMN02 (Clonidine)",
          "N21FAR7B4S (Apomorphine)",
          "OOM10GW9UE (4-iodo-2,5-dimethoxyphenylisopropylamine)"
     ],
     "SB": "IM",
     "MH": [
          "8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology",
          "Action Potentials/drug effects",
          "Adrenergic alpha-2 Receptor Agonists",
          "Amphetamines/pharmacology",
          "Animals",
          "Apomorphine/pharmacology",
          "Brain/*cytology",
          "Clonidine/pharmacology",
          "Dose-Response Relationship, Drug",
          "Heterocyclic Compounds, 4 or More Rings/*pharmacology",
          "Male",
          "Neurons/*drug effects/physiology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptor, Serotonin, 5-HT1A/*physiology",
          "Receptor, Serotonin, 5-HT2A/*physiology",
          "Receptors, Adrenergic, alpha-2/*physiology",
          "Receptors, Dopamine D2/agonists",
          "Serotonin 5-HT1 Receptor Agonists",
          "Serotonin 5-HT2 Receptor Agonists"
     ],
     "EDAT": "2009/01/01 09:00",
     "MHDA": "2009/05/21 09:00",
     "CRDT": [
          "2009/01/01 09:00"
     ],
     "PHST": [
          "2008/08/08 00:00 [received]",
          "2008/09/23 00:00 [revised]",
          "2008/11/04 00:00 [accepted]",
          "2009/01/01 09:00 [entrez]",
          "2009/01/01 09:00 [pubmed]",
          "2009/05/21 09:00 [medline]"
     ],
     "AID": [
          "S0924-977X(08)00275-7 [pii]",
          "10.1016/j.euroneuro.2008.11.001 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur Neuropsychopharmacol. 2009 Mar;19(3):177-87. doi: 10.1016/j.euroneuro.2008.11.001. Epub 2008 Dec 29.",
     "term": "hippocampus"
}